October 10, 2025- Medtronic plc announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world’s first closed-loop DBS system for people with Parkinson’s – has been recognized by TIME on its annual list of Best Inventions.
There are over 10 million people living with Parkinson’s disease globally, and while there is currently no cure, Medtronic deep brain stimulation (DBS) has been transforming the lives of people with Parkinson’s and other neurological disorders for more than 30 years. Medtronic recently enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology for people with Parkinson’s. This feature personalizes therapy based on a patient’s brain activity in real time – minimizing the need for patients to manually adjust stimulation.
For over two decades, TIME has recognized the products, software, and services shaping the world – from breakthroughs in science and technology to innovations that make daily life smarter, easier, and more sustainable. This year’s honorees span notable categories from artificial intelligence and immersive technology to accessibility, logistics, and healthcare. All entries are thoughtfully assessed by TIME’s esteemed editors on impact, innovation, and success.
Medtronic spent more than twenty years developing a complete, sensing-enabled DBS system leveraging exclusive BrainSense™ technology to detect, capture, and classify different brain signals. This advancement put Medtronic at the forefront of incorporating therapeutic brain-computer interface (BCI) technology into DBS therapy and BrainSense™ Adaptive DBS presents the largest commercial launch of BCI technology – ever. Medtronic received both CE Mark and U.S. FDA approval for BrainSense™ aDBS earlier this year and already more than 1,000 patients worldwide have received the adaptive therapy.